Older patients are eligible for trial of lithium and valproate [7]

British Medical Journal

Volumn 327, Issue 7411, 2003, Pages 395-396

  Rendell, Jennifer M ^a   Geddes, John R ^a   Ostacher, Michael J ^b  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; VALPROIC ACID;

AGE; AGED; BIPOLAR DISORDER; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG USE; HUMAN; LETTER; PRESCRIPTION; PRIORITY JOURNAL; RELAPSE; RELIABILITY; SAMPLING;

AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; HUMANS; LITHIUM CARBONATE; VALPROIC ACID;

EID: 0042232058     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Shulman KI, Rochon P, Sykora K, Anderson G, Mamdani M, Bronskill S, Tran CTT. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ 2003;326:960-1. (3 May.)
2. Fenn HH, Robinson D, Luby V, Dangel C, Buxton E, Beattie M, et al. Trends in pharmacotherapy of schizoaffective and bipolar affective disorders: a 5-year naturalistic study. Am J Psychiatry 1996;153:711-3.
3. Geddes JR, Goodwin GM, Rendell JM, Hainsworth J, Van der Gucht E, Young H. New trial should clarify lithium use in bipolar disorder. BMJ 2002;325:441.
4. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I. Arch Gen Psychiatry 2000;57:481-9.
5. Baldessarini RJ, Tohen M, Tondo L. Maintenance treatment in bipolar disorder. Arch Gen Psychiatry 2000;57:490-2.